Yang Su

482 total citations
30 papers, 246 citations indexed

About

Yang Su is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yang Su has authored 30 papers receiving a total of 246 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Yang Su's work include Heart Failure Treatment and Management (7 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiac pacing and defibrillation studies (3 papers). Yang Su is often cited by papers focused on Heart Failure Treatment and Management (7 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiac pacing and defibrillation studies (3 papers). Yang Su collaborates with scholars based in China, Hong Kong and United States. Yang Su's co-authors include Yawei Xu, Dachun Xu, Weijing Liu, Fenglei Zhang, Yuyan Lu, Xianling Zhang, Sang‐Bing Ong, Wenhui Peng, Hailing Li and Baowei Zhang and has published in prestigious journals such as Journal of Clinical Oncology, The FASEB Journal and Small.

In The Last Decade

Yang Su

25 papers receiving 244 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yang Su China 11 104 60 44 40 31 30 246
Cecilia Kennbäck Sweden 8 129 1.2× 63 1.1× 35 0.8× 19 0.5× 37 1.2× 14 259
István Adorján Szabó Romania 8 99 1.0× 105 1.8× 43 1.0× 20 0.5× 58 1.9× 21 246
Shi-liang Jiang China 9 139 1.3× 68 1.1× 42 1.0× 19 0.5× 28 0.9× 41 306
Zhenyu Liu China 10 107 1.0× 84 1.4× 70 1.6× 26 0.7× 44 1.4× 27 289
Yu Hashimoto Japan 10 73 0.7× 68 1.1× 25 0.6× 21 0.5× 18 0.6× 42 229
Anna Szpakowicz Poland 10 115 1.1× 75 1.3× 23 0.5× 14 0.3× 21 0.7× 31 247
Sabrina H. van Ierssel Belgium 8 73 0.7× 157 2.6× 41 0.9× 31 0.8× 58 1.9× 20 285
An Zhang China 8 35 0.3× 80 1.3× 78 1.8× 28 0.7× 30 1.0× 30 310
Jinfa Jiang China 11 144 1.4× 194 3.2× 36 0.8× 74 1.9× 49 1.6× 30 370

Countries citing papers authored by Yang Su

Since Specialization
Citations

This map shows the geographic impact of Yang Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yang Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yang Su more than expected).

Fields of papers citing papers by Yang Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yang Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yang Su. The network helps show where Yang Su may publish in the future.

Co-authorship network of co-authors of Yang Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yang Su. A scholar is included among the top collaborators of Yang Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yang Su. Yang Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Weijie, Zhiguo Nie, Lingyun Li, et al.. (2025). A network pharmacological target mendelian randomization study on the neuroprotective effects of active ingredients in mahuang fuzi xixin decoction for multiple sclerosis. Journal of Asian Natural Products Research. 28(1). 91–111. 1 indexed citations
2.
3.
4.
Luo, Jinlian, et al.. (2025). Job crafting towards strengths and interests: how overqualification enhances creativity?. Service Industries Journal. 45(15-16). 1421–1445. 2 indexed citations
5.
Mohammed, Abdul‐Quddus, Yongqiang Luo, Yi-Chuan Chen, et al.. (2025). Association of systemic immune-inflammation index with adverse outcomes in heart failure and preserved ejection fraction. Journal of Translational Medicine. 23(1). 957–957.
6.
Li, Ling, Muhammad Ahsan, Zhe Li, et al.. (2024). Transcriptome analysis of high- and low-selenium genotypes identifies genes responsible for selenium absorption, translocation, and accumulation. Frontiers in Plant Science. 15. 1413549–1413549. 3 indexed citations
7.
Xu, Yanhua, Wenqing Zhu, Yang Su, et al.. (2024). Characterization of a novel mitophagy-related 5-genes signature for diagnosis of acute myocardial infarction. Vascular Pharmacology. 156. 107417–107417. 1 indexed citations
8.
Mohammed, Abdul‐Quddus, Yongqiang Luo, Kaitao Wang, et al.. (2024). Stress hyperglycemia ratio as a prognostic indicator for long-term adverse outcomes in heart failure with preserved ejection fraction. Cardiovascular Diabetology. 23(1). 67–67. 19 indexed citations
9.
Xu, Yanhua, Yifan Liu, Zeyu Wang, et al.. (2023). Plasma GAS6 predicts mortality risk in acute heart failure patients: insights from the DRAGON-HF trial. Journal of Translational Medicine. 21(1). 21–21. 6 indexed citations
10.
Liu, Yifan, Yawei Xu, Chen Chi, et al.. (2022). Prognostic Value of Plasma sAXL in Patients with Heart Failure: Insights from the DRAGON-HF Trial. ESC Heart Failure. 10(1). 661–672. 2 indexed citations
11.
Jia, Xuebing, Lei Li, Fan Wang, et al.. (2022). DUB3/KLF4 combats tumor growth and chemoresistance in hepatocellular carcinoma. Cell Death Discovery. 8(1). 166–166. 10 indexed citations
12.
Wang, Cheng, Yan Wu, Yang Su, et al.. (2022). Elevated levels of sIL-2R, TNF-α and hs-CRP are independent risk factors for post percutaneous coronary intervention coronary slow flow in patients with non-ST segment elevation acute coronary syndrome. The International Journal of Cardiovascular Imaging. 38(6). 1191–1202. 2 indexed citations
13.
Su, Yang, Chenming Wu, Yi‐Ming Chang, et al.. (2022). USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells. Breast Cancer Research and Treatment. 196(1). 31–44. 13 indexed citations
14.
15.
Xu, Yanhua, Yang Su, Sang‐Bing Ong, et al.. (2021). Single-Cell Transcriptome Analysis Decipher New Potential Regulation Mechanism of ACE2 and NPs Signaling Among Heart Failure Patients Infected With SARS-CoV-2. Frontiers in Cardiovascular Medicine. 8. 628885–628885. 18 indexed citations
16.
Wang, Wei, Yang Su, Yuxi Sun, et al.. (2020). Optimal duration of Vitamin K antagonists anticoagulant therapy after venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders. 20(1). 53–53. 1 indexed citations
17.
Su, Yang, Zeyu Wang, Bin Dong, et al.. (2020). Efficacy of Early Initiation of Ivabradine Treatment in Patients with Acute Heart Failure: Rationale and Design of SHIFT-AHF Trial. ESC Heart Failure. 7(6). 4465–4471. 7 indexed citations
18.
Xu, Xianming, Juan Wen, Yao Lu, et al.. (2016). Impact of age on plasma vaspin concentration in a group of normal Chinese people. Journal of Endocrinological Investigation. 40(2). 143–151. 10 indexed citations
19.
20.
Zhang, Baowei, Wenhui Peng, Hailing Li, et al.. (2013). Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions. Clinical Biochemistry. 46(15). 1520–1525. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cecilia Kennbäck Breakdown of academic impact, for papers by István Adorján Szabó Breakdown of academic impact, for papers by Shi-liang Jiang Breakdown of academic impact, for papers by Zhenyu Liu Breakdown of academic impact, for papers by Yu Hashimoto Breakdown of academic impact, for papers by Anna Szpakowicz Breakdown of academic impact, for papers by Sabrina H. van Ierssel Breakdown of academic impact, for papers by An Zhang Breakdown of academic impact, for papers by Jinfa Jiang
Rankless by CCL
2026